Home > Insider Trading > Filing (0001214659-20-000278)

Filing Details

Accession Number:: 0001214659-20-000278
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-01-10 16:21:32
Reporting Period:: 2019-12-23

Accepted Time:: 2020-01-10 16:21:32
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1586105	Zyla Life Sciences	ZCOR	Pharmaceutical Preparations (2834)	463575334

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1676700	Riva Ridge Capital Management Lp	55 Fifth Street, Suite 1808 New York New York NY 10003	No	No	No	No
1777278	Riva Ridge Gp Llc	55 Fifth Street, Suite 1808 New York New York NY 10003	No	No	No	No
1777279	James Shim	55 Fifth Street, Suite 1808 New York New York NY 10003	No	No	No	No
1777281	H Stephen Golden	55 Fifth Street, Suite 1808 New York New York NY 10003	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.001 Per Share	Disposition	2019-12-23	250,000	$2.50	988,661	No	4	S	Indirect	See Footnotes
Common Stock, Par Value $0.001 Per Share	Disposition	2019-12-30	50,000	$2.50	938,661	No	4	S	Indirect	See Footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnotes
No	4	S	Indirect	See Footnotes

Footnotes

This Form 4 is being filed jointly by Riva Ridge Capital Management LP, a Delaware limited partnership ("RRCM"), Riva Ridge GP LLC, a Delaware limited liability company ("RRGP"), Stephen H. Golden ("Golden"), an individual, and James Shim ("Shim"), an individual (together, the "Reporting Persons"), with respect to certain securities of Zyla Life Sciences (f/k/a Egalet Corporation) (the "Issuer"). Neither the filing of this Form 4 nor any statements herein shall be deemed an admission that the Reporting Persons are members of a group, within the meaning of Section 13(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), with respect to any equity securities of the Issuer.
RRCM is the investment adviser to certain investment funds and accounts, including Riva Ridge Master Fund, Ltd., a Cayman Islands exempted company (the "Master Fund"). The securities reported in this row are held directly by the Master Fund.
Each of RRCM, as the investment adviser to the Master Fund, and RRGP, as the general partner of RRCM, may be deemed a beneficial owner of the Issuer's securities held by the Master Fund. Each of Golden and Shim, as a managing member of RRGP with the power to exercise investment discretion, may be deemed a beneficial owner of the Issuer's securities held by the Master Fund. Each of the Reporting Persons disclaims beneficial ownership of any securities of the Issuer reported or referenced herein, for purposes of Section 16 of the Exchange Act or otherwise, except to the extent of such Reporting Person's pecuniary interest, if any, therein.